Cesare Astori
Policlinico San Matteo Fondazione(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes(2013)576 cited
- → Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis(2014)381 cited
- → Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms(2013)92 cited
- Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.(2000)
- → CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis(2014)71 cited
- → The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders(1999)66 cited